Coloplast A/S (OTCMKTS:CLPBY) Hits New 12-Month Low – Should You Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) hit a new 52-week low during trading on Monday . The company traded as low as $7.71 and last traded at $7.72, with a volume of 21594 shares traded. The stock had previously closed at $7.81.

Analyst Ratings Changes

Separately, Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Coloplast A/S has an average rating of “Hold”.

Coloplast A/S Stock Down 1.9%

The stock’s 50-day simple moving average is $8.64 and its 200-day simple moving average is $9.07. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The firm has a market capitalization of $17.26 billion, a P/E ratio of 28.37, a P/E/G ratio of 0.77 and a beta of 0.26.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.08% and a net margin of 14.35%.The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.12 billion. As a group, research analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.